GAM: Suture, Absorbable, Synthetic, Polyglycolic Acid
What it covers
An absorbable poly(glycolide/l-lactide) surgical suture (PGL suture) is an absorbable sterile, flexible strand as prepared and synthesized from homopolymers of glycolide and copolymers made from 90 percent glycolide and 10 percent l-lactide, and is indicated for use in soft tissue approximation. A PGL suture meets United States Pharmacopeia (U.S.P.) requirements as described in the U.S.P. “Monograph for Absorbable Surgical Sutures;” it may be monofilament or multifilament (braided) in form; it may be uncoated or coated; and it may be undyed or dyed with an FDA-approved color additive. Also, the suture may be provided with or without a standard needle attached.
The identification in 21 CFR 878.4493, absorbable poly(glycolide/l-lactide) surgical suture. FDA gives GAM no definition of its own, so the regulation’s describes it.
FDA flags GAM devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K263073 | Fast Absorbing PGLA | Riverpoint Medical, LLC | Sep 29, 2026 | Special |
| K253394 | Coated VICRYL (Polyglactin 910) Plus Antibacterial Suture | ETHICON, Inc. | Jun 25, 2026 | Traditional |
| K253530 | Trexon Monofilament Synthetic Absorbable Suture | Medtronic | May 28, 2026 | Traditional |
| K253852 | MONOCRYL Plus Antibacterial Poliglecaprone 25 (Monofilament), Sterile Synthetic Absorbable Surgical Suture | ETHICON, Inc. | Feb 6, 2026 | Traditional |
| K252743 | STRATAFIX Spiral PDS Plus Knotless Tissue Control Device; STRATAFIX Spiral MONOCRYL Plus Knotless Tissue Control Device | ETHICON, Inc. | Dec 22, 2025 | Traditional |
| K253620 | TroClose 1200 | Gordian Surgical, Ltd. | Dec 16, 2025 | Special |
| K252820 | PGLA90 Poly(glycolide-co-L-lactide) Surgical Sutures (Calypso); PGLA90 Poly(glycolide-co-L-lactide) Surgical Sutures (Odysseus) | Internacional Farmacéutica S.A DE C.V | Oct 3, 2025 | Special |
| K233265 | Monotime and Optime R | Peters Surgical | Oct 11, 2024 | Abbreviated |
| K232372 | Peters Surgical ADVANTIME Absorbable Suture (ADVANTIME) | Peters Surgical | Jul 12, 2024 | Abbreviated |
| K221527 | StitchKit | Origami Surgical Inc . | Feb 14, 2023 | Traditional |
Clearances by year
60 GAM 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 4 | 131 |
| 2025 | 3 | 29 |
| 2024 | 2 | 359 |
| 2023 | 1 | 264 |
| 2022 | 2 | 244 |
| 2021 | 2 | 91 |
| 2020 | 3 | 140 |
| 2019 | 4 | 90 |
| 2018 | 5 | 98 |
| 2017 | 8 | 134 |
| 2016 | 3 | 169 |
| 2015 | 5 | 209 |
| 2014 | 10 | 121 |
| 2013 | 1 | 184 |
| 2012 | 5 | 31 |
| 2011 | 2 | 79 |
Who submits
28 applicants cleared a GAM device since 2011. 67% of the clearances went to applicants in United States, then China (10%), South Korea (7%) and Israel (5%). By type: Traditional 70%, Special 23% and Abbreviated 7%.
| Applicant | Clearances since 2011 |
|---|---|
| ETHICON, Inc. | 12 |
| Foosin Medical Supplies Inc., Ltd. | 5 |
| Aesculap, Inc. | 3 |
| Gordian Surgical, Ltd. | 3 |
| Silhouette Lift, Inc. | 3 |
| Sm Eng Co., Ltd. | 3 |
| Surgical Specialties Corp | 3 |
| Surgical Specialties Corp. Dba Angiotech | 3 |
How FDA classifies it
Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.
From 21 CFR 878.4493. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 878.4493 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GAM clearances declared.
Ask about GAM
Questions about GAM
What is FDA product code GAM?
Product code GAM, “Suture, Absorbable, Synthetic, Polyglycolic Acid” in FDA's classification database, is a Class II device type under 21 CFR 878.4493 (absorbable poly(glycolide/l-lactide) surgical suture), reviewed by FDA's General, Plastic Surgery panel. FDA's 510(k) database lists 150 clearances under GAM, 60 of them since 2011.
How many 510(k) clearances are there under GAM?
FDA’s 510(k) database listed 150 clearances under GAM as of Oct 29, 2026, 60 of them decided since 2011; the most recent decision was Sep 29, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a GAM 510(k)?
For the 7 GAM clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 66 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most GAM clearances?
Since 2011: ETHICON, Inc. (12), Foosin Medical Supplies Inc., Ltd. (5), Aesculap, Inc. (3), Gordian Surgical, Ltd. (3) and Silhouette Lift, Inc. (3). 28 applicants have cleared a GAM device in that time.